mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.001 |
mRNA |
skepinone-L |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.001 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.002 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
MS-275 |
FIMM |
pan-cancer |
AAC |
0.38 |
0.003 |
mRNA |
Vorinostat |
FIMM |
pan-cancer |
AAC |
0.44 |
0.003 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |